| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | TAE684 | CCLE | pan-cancer | AAC | -0.055 | 0.2 |
| mRNA | TKI258 | CCLE | pan-cancer | AAC | -0.045 | 0.3 |
| mRNA | Erlotinib | CCLE | pan-cancer | AAC | 0.04 | 0.4 |
| mRNA | RAF265 | CCLE | pan-cancer | AAC | -0.042 | 0.4 |
| mRNA | LBW242 | CCLE | pan-cancer | AAC | -0.041 | 0.4 |
| mRNA | Sorafenib | CCLE | pan-cancer | AAC | -0.035 | 0.5 |
| mRNA | Panobinostat | CCLE | pan-cancer | AAC | 0.031 | 0.5 |
| mRNA | Crizotinib | CCLE | pan-cancer | AAC | -0.029 | 0.5 |
| mRNA | AEW541 | CCLE | pan-cancer | AAC | 0.022 | 0.6 |
| mRNA | Nilotinib | CCLE | pan-cancer | AAC | 0.022 | 0.7 |